Genentech Announces Phase III Study Results for Tecentriq Plus Cotellic and...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced the Phase III IMspire150 study in people with previously untreated BRAF V600 mutationpositive advanced melanoma met its...
View ArticleResearchers identify link in the treatment of inflammatory bowel disease
A new study involving Oxford researchers has revealed how the antiinflammatory cytokine IL10 and lipid mediator prostaglandin E2 PGE2 work together to prevent inflammatory tissue damage and maintain a...
View ArticleSynedgen Awarded Funding to Advance Inflammatory Bowel Disease Treatments
Glycopolymers aimed at reducing inflammation and damage associated with ulcerations of the lower bowel Synedgen a biotechnology company using glycochemistry to develop drugs that enhance and mimic the...
View ArticleIntegrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Pipeline Review H1...
Integrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Pipeline Review H1 2019SummaryAccording to the recently published report 'Integrin Beta 7 Pipeline Review H1 2019'; Integrin Beta 7 Gut Homing...
View ArticleBiosimilar for Crohn's Noninferior to Adalimumab
A patent dispute means that the marketing of a biosimilar for patients with inflammatory bowel disease will be delayed despite approval by the US Food and Drug Administration investigators report....
View ArticleGlutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019 Published by...
Glutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019SummaryAccording to the recently published report 'Glutamate Receptor Ionotropic NMDA 2B Pipeline Review H2 2019'; Glutamate Receptor...
View ArticleIntegrin Beta 7 Pipeline Review H2 2019 Published by Global Markets Direct...
Integrin Beta 7 Pipeline Review H2 2019SummaryIntegrin Beta 7 Gut Homing Receptor Beta Subunit or ITGB7 Integrin beta7 is an integrin protein encoded by the ITGB7 gene. It interacts with the cell...
View ArticleNatco Pharma Ltd NATCOPHARM Financial and Strategic SWOT Analysis Review...
Natco Pharma Ltd NATCOPHARM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleMeiji Seika Pharma and DongA Socio Holdings Initiate Phase I Clinical Trial...
Meiji Seika Pharma Co. Ltd. Headquarters Tokyo Japan President and Representative Director Daikichiro Kobayashi Meiji and DongA Socio Holdings Co. Ltd. Headquarters Seoul Korea CEO Jong Hyun Han DongA...
View ArticleReporters invited to attend Crohn's & Colitis CongressÂ
American Gastroenterological Association Register for the Crohn's & Colitis Congress taking place Jan. 2325 2020 in Austin Texas and learn about the latest trends and research in inflammatory bowel...
View ArticleAdalimumab Biosimilar Comparable for Crohn's Disease
>MedPage Today ORLANDO A biosimilar of adalimumab Humira was comparable to the drug to treat Crohn's disease a researcher said here.The biosimilar BI 695501 Boehringer Ingelheim demonstrated...
View ArticleStudy Blocking IL1 protein decreases severity of inflammation in Crohn's disease
Investigators at the Case Western Reserve University School of Medicine discovered that blocking interleukin1 IL1 a protein that controls inflammation in the gut markedly decreases the severity of...
View ArticleSangamo Highlights Advancements in Genomic Medicine Pipeline and Expanded R&D...
IND transfer to Pfizer for SB525 hemophilia A gene therapy is substantially completed; Pfizer is advancing SB525 into a Phase 3 registrational study in 2020At R&D Day Sangamo is detailing...
View ArticleGelesis Announces Partnership with Ro on Commercial Launch of Plenity
In addition to collaborating with traditional healthcare providers Gelesis will leverage Ros nationwide telehealth services to make Plenity available to patients who dont have an established healthcare...
View ArticleTheravance Biopharma Inc TBPH Financial and Strategic SWOT Analysis Review...
Theravance Biopharma Inc TBPH Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleNeuClone Completes Dosing in Phase I Clinical Trial of Stelara ustekinumab...
NeuClone Pharmaceuticals Ltd NeuClone a clinicalstage biopharmaceutical company exclusively focused on developing highquality biosimilar products today announced successful recruitment and dosing of...
View ArticleTiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review...
Tiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleColitis Pipeline Review H2 2019 Published by Global Markets Direct Prices...
Colitis Pipeline Review H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis Pipeline Review H2 2019 provides an overview of the Colitis...
View ArticleOutlook Therapeutics Inc ONSIU Financial and Strategic SWOT Analysis Review...
SummaryOutlook Therapeutics IncOutlook Therapeutics formerly known as Oncobiologics Inc is a clinical stage biopharmaceutical company that identifies develops manufactures and commercializes biosimilar...
View Article